Navegar

Colección

Datos Estadísticas

Lista de

metabolic disorder
8
"Involvement of leptin in the molecular physiology of the placenta" (2018) Schanton, M.;Maymó, J.L.;Pérez-Pérez, A. (...)Varone, C.L. Reproduction. 155(1):R1-R12
"Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis" (2013) S. Belforte, F.; Coluccio Leskow, F.; Poskus, E.; Penas Steinhardt, A. Molecular Biology Reports. 40(4):3015-3020
"FKBP51 and FKBP52 in signaling and disease" (2011) Storer, C.L.;Dickey, C.A.;Galigniana, M.D. (...)Cox, M.B. Trends in Endocrinology and Metabolism. 22(12):481-490
"CYP2D6 polymorphisms in patients with porphyrias" (2006) Lavandera, J.V.; Parera, V.E.; Batlle, A.; Buzaleh, A.M. Molecular Medicine. 12(9-10):259-263
"Signaling processes in tumoral neuroendocrine pituitary cells as potential targets for therapeutic drugs" (2005) Paez-Pereda, M.;Giacomini, D.;Echenique, C. (...)Arzt, E. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 5(3):259-267
"Glutathione depletion and anaesthesia in mice alter heme and drug metabolising enzymes" (2005) Buzaleh, A.M.; Batlle, A.M.D.C. Biochimica et Biophysica Acta - General Subjects. 1723(1-3):128-134
"Phospholipid alterations elicited by hexachlorobenzene in rat brain are strain-dependent and porphyria-independent" (2001) Cochón, A.C.; San Martín De Viale, L.C.; Billi De Catabbi, S.C. Comparative Biochemistry and Physiology - C Toxicology and Pharmacology. 130(2):199-207